While no significant differences were observed in other cognitive measures or BDNF levels, these findings suggest that high-dose probiotics could offer a promising therapeutic strategy for cognitive dysfunction in depression, despite the study’s modest sample size and specific formulation [146]. Here, BDNF is linked to depressive symptom measurement.